Published in Mol Cell on April 01, 2003
Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol Cell (2008) 6.93
Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc Natl Acad Sci U S A (2004) 4.19
Phosphorylation of CBP by IKKalpha promotes cell growth by switching the binding preference of CBP from p53 to NF-kappaB. Mol Cell (2007) 3.42
The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. Nucleic Acids Res (2004) 3.30
Mechanisms, regulation and consequences of protein SUMOylation. Biochem J (2010) 3.22
Class II histone deacetylases: from sequence to function, regulation, and clinical implication. Mol Cell Biol (2005) 3.05
PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing. Mol Cell (2007) 2.77
Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors. AIDS (2009) 2.28
CREB binds to multiple loci on human chromosome 22. Mol Cell Biol (2004) 2.28
Global analyses of sumoylated proteins in Saccharomyces cerevisiae. Induction of protein sumoylation by cellular stresses. J Biol Chem (2004) 2.27
Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors. Mol Cell Biol (2005) 2.18
Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. Mol Cell Biol (2006) 2.01
Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development. Mol Cell Biol (2006) 2.00
Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formation. EMBO J (2007) 1.97
Role of desumoylation in the development of prostate cancer. Neoplasia (2006) 1.90
SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1. Mol Cell Biol (2004) 1.89
Malleable machines take shape in eukaryotic transcriptional regulation. Nat Chem Biol (2008) 1.76
Regulating histone acetyltransferases and deacetylases. EMBO Rep (2003) 1.76
An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity. Mol Cell Biol (2007) 1.69
Detection of protein SUMOylation in vivo. Nat Protoc (2009) 1.66
Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy. Proc Natl Acad Sci U S A (2003) 1.60
NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression. Proc Natl Acad Sci U S A (2006) 1.59
Physical and functional HAT/HDAC interplay regulates protein acetylation balance. J Biomed Biotechnol (2010) 1.55
Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol Cell Biol (2005) 1.55
Intrinsic structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse processes. J Virol (2008) 1.53
SUMO: a multifaceted modifier of chromatin structure and function. Dev Cell (2013) 1.50
Role of the PLDLS-binding cleft region of CtBP1 in recruitment of core and auxiliary components of the corepressor complex. Mol Cell Biol (2007) 1.49
SUMO-dependent compartmentalization in promyelocytic leukemia protein nuclear bodies prevents the access of LRH-1 to chromatin. Mol Cell Biol (2005) 1.48
Ikaros SUMOylation: switching out of repression. Mol Cell Biol (2005) 1.48
Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression. J Biol Chem (2008) 1.44
SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation. EMBO J (2009) 1.41
A small conserved surface in SUMO is the critical structural determinant of its transcriptional inhibitory properties. Mol Cell Biol (2005) 1.40
SUMO modification regulates inactivation of the voltage-gated potassium channel Kv1.5. Proc Natl Acad Sci U S A (2007) 1.39
SUMO modification negatively modulates the transcriptional activity of CREB-binding protein via the recruitment of Daxx. Proc Natl Acad Sci U S A (2005) 1.33
Regulation of the SUMO pathway sensitizes differentiating human endometrial stromal cells to progesterone. Proc Natl Acad Sci U S A (2006) 1.32
Role for SUMO modification in facilitating transcriptional repression by BKLF. Mol Cell Biol (2005) 1.31
Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3). Proc Natl Acad Sci U S A (2003) 1.29
Negative modulation of androgen receptor transcriptional activity by Daxx. Mol Cell Biol (2004) 1.26
Kaposi's sarcoma-associated herpesvirus K-bZIP represses gene transcription via SUMO modification. J Virol (2005) 1.26
PIASx acts as an Elk-1 coactivator by facilitating derepression. EMBO J (2005) 1.25
Estrogen receptor alpha represses transcription of early target genes via p300 and CtBP1. Mol Cell Biol (2009) 1.22
SUMO conjugation attenuates the activity of the gypsy chromatin insulator. EMBO J (2006) 1.22
DNA damage-induced heterogeneous nuclear ribonucleoprotein K sumoylation regulates p53 transcriptional activation. J Biol Chem (2012) 1.21
Myocardin sumoylation transactivates cardiogenic genes in pluripotent 10T1/2 fibroblasts. Mol Cell Biol (2006) 1.20
Sumoylation of EKLF promotes transcriptional repression and is involved in inhibition of megakaryopoiesis. Mol Cell Biol (2007) 1.20
SUMO functions in constitutive transcription and during activation of inducible genes in yeast. Genes Dev (2010) 1.20
Sumoylation regulates multiple aspects of mammalian poly(A) polymerase function. Genes Dev (2008) 1.19
SUMO modified proteins localize to the XY body of pachytene spermatocytes. Chromosoma (2004) 1.18
Repression of Smad4 transcriptional activity by SUMO modification. Biochem J (2004) 1.17
Ubiquitin-dependent regulation of G protein-coupled receptor trafficking and signaling. Cell Signal (2012) 1.16
SUMOylation attenuates the function of PGC-1alpha. J Biol Chem (2009) 1.14
RNF4 and VHL regulate the proteasomal degradation of SUMO-conjugated Hypoxia-Inducible Factor-2alpha. Nucleic Acids Res (2009) 1.12
SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX. Mol Endocrinol (2008) 1.12
Transcriptional regulation of human dual specificity protein phosphatase 1 (DUSP1) gene by glucocorticoids. PLoS One (2010) 1.12
EBNA3C coactivation with EBNA2 requires a SUMO homology domain. J Virol (2004) 1.12
SUMO-1-dependent allosteric regulation of thymine DNA glycosylase alters subnuclear localization and CBP/p300 recruitment. Mol Cell Biol (2006) 1.11
The SIRT2 deacetylase regulates autoacetylation of p300. Mol Cell (2008) 1.11
Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activity. BMC Biochem (2006) 1.10
Sumoylation pathway is required to maintain the basal breast cancer subtype. Cancer Cell (2014) 1.10
Regulation of MBD1-mediated transcriptional repression by SUMO and PIAS proteins. EMBO J (2006) 1.09
Sumoylation and regulation of cardiac gene expression. Circ Res (2010) 1.08
Distinct roles for the essential MYST family HAT Esa1p in transcriptional silencing. Mol Biol Cell (2006) 1.08
SUMO conjugation in plants. Planta (2004) 1.07
SUMO-1 modification of MEF2A regulates its transcriptional activity. J Cell Mol Med (2006) 1.06
Uncovering ubiquitin and ubiquitin-like signaling networks. Chem Rev (2011) 1.06
SUMOylation of the corepressor N-CoR modulates its capacity to repress transcription. Mol Biol Cell (2006) 1.04
The functional significance of nuclear receptor acetylation. Steroids (2007) 1.04
Corepressive action of CBP on androgen receptor transactivation in pericentric heterochromatin in a Drosophila experimental model system. Mol Cell Biol (2008) 1.04
Bioinformatic analysis and post-translational modification crosstalk prediction of lysine acetylation. PLoS One (2011) 1.04
SUMO modification regulates the transcriptional activity of XBP1. Biochem J (2010) 1.03
MafG sumoylation is required for active transcriptional repression. Mol Cell Biol (2006) 1.02
Growth factor-induced phosphorylation of sterol regulatory element-binding proteins inhibits sumoylation, thereby stimulating the expression of their target genes, low density lipoprotein uptake, and lipid synthesis. J Biol Chem (2008) 1.02
Modulation of histone deacetylase 6 (HDAC6) nuclear import and tubulin deacetylase activity through acetylation. J Biol Chem (2012) 1.00
Biochemical pathways that regulate acetyltransferase and deacetylase activity in mammalian cells. Trends Biochem Sci (2009) 0.99
Function of histone deacetylase 6 as a cofactor of nuclear receptor coregulator LCoR. J Biol Chem (2009) 0.99
Chromatin modification by SUMO-1 stimulates the promoters of translation machinery genes. Nucleic Acids Res (2012) 0.98
Sumoylation of forkhead L2 by Ubc9 is required for its activity as a transcriptional repressor of the Steroidogenic Acute Regulatory gene. Cell Signal (2009) 0.97
AP-2gamma promotes proliferation in breast tumour cells by direct repression of the CDKN1A gene. EMBO J (2009) 0.97
Role of SUMO/Ubc9 in DNA damage repair and tumorigenesis. J Mol Histol (2006) 0.96
SUMO1 negatively regulates BRCA1-mediated transcription, via modulation of promoter occupancy. Nucleic Acids Res (2007) 0.95
CBP/p300 is a cell type-specific modulator of CLOCK/BMAL1-mediated transcription. Mol Brain (2009) 0.95
Small ubiquitin-like modifier modification of arrestin-3 regulates receptor trafficking. J Biol Chem (2010) 0.94
Metabolism, cytoskeleton and cellular signalling in the grip of protein Nepsilon - and O-acetylation. EMBO Rep (2007) 0.94
Sumoylation and the function of CCAAT enhancer binding protein alpha (C/EBP alpha). Blood Cells Mol Dis (2008) 0.92
SUMO-2 Orchestrates Chromatin Modifiers in Response to DNA Damage. Cell Rep (2015) 0.92
Oncogenesis driven by the Ras/Raf pathway requires the SUMO E2 ligase Ubc9. Proc Natl Acad Sci U S A (2015) 0.92
A unique SUMO-2-interacting motif within LANA is essential for KSHV latency. PLoS Pathog (2013) 0.91
Controlling a master switch of adipocyte development and insulin sensitivity: covalent modifications of PPARγ. Biochim Biophys Acta (2012) 0.91
Synergistic activation of human involucrin gene expression by Fra-1 and p300--evidence for the presence of a multiprotein complex. J Invest Dermatol (2007) 0.91
A SUMO-regulated activation function controls synergy of c-Myb through a repressor-activator switch leading to differential p300 recruitment. Nucleic Acids Res (2010) 0.90
Histone modifications: Now summoning sumoylation. Proc Natl Acad Sci U S A (2003) 0.89
Modification of papillomavirus E2 proteins by the small ubiquitin-like modifier family members (SUMOs). Virology (2008) 0.89
Post-Translational Modifications of Kaposi's Sarcoma-Associated Herpesvirus Regulatory Proteins - SUMO and KSHV. Front Microbiol (2012) 0.89
An evolving understanding of nuclear receptor coregulator proteins. J Mol Endocrinol (2013) 0.89
Transcriptional Suppression by Transient Recruitment of ARIP4 to Sumoylated nuclear receptor Ad4BP/SF-1. Mol Biol Cell (2009) 0.88
Insights into the molecular activation mechanism of the RhoA-specific guanine nucleotide exchange factor, PDZRhoGEF. J Biol Chem (2011) 0.87
Characterization of the loss of SUMO pathway function on cancer cells and tumor proliferation. PLoS One (2015) 0.87
Involvement of the SMRT/NCoR-HDAC3 complex in transcriptional repression by the CNOT2 subunit of the human Ccr4-Not complex. Biochem J (2006) 0.87
SUMOylation of ZFP282 potentiates its positive effect on estrogen signaling in breast tumorigenesis. Oncogene (2012) 0.87
RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat Cell Biol (2008) 5.90
Histone deimination antagonizes arginine methylation. Cell (2004) 5.19
Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity. Cell (2004) 4.46
Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1. Science (2009) 3.68
System-wide changes to SUMO modifications in response to heat shock. Sci Signal (2009) 3.50
Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol Cell (2004) 3.45
Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysis. Nature (2012) 2.86
Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol Cell Proteomics (2006) 2.64
SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1. J Biol Chem (2005) 2.59
An additional role for SUMO in ubiquitin-mediated proteolysis. Nat Rev Mol Cell Biol (2009) 2.27
Zinc-finger protein-targeted gene regulation: genomewide single-gene specificity. Proc Natl Acad Sci U S A (2003) 2.24
Single-stranded DNA-binding protein hSSB1 is critical for genomic stability. Nature (2008) 2.12
Reanalysis of phosphoproteomics data uncovers ADP-ribosylation sites. Nat Methods (2012) 2.12
The DEAD box protein p68: a novel transcriptional coactivator of the p53 tumour suppressor. EMBO J (2005) 2.12
SUMOylation of the GTPase Rac1 is required for optimal cell migration. Nat Cell Biol (2010) 1.95
A mechanism for inhibiting the SUMO pathway. Mol Cell (2004) 1.93
A proteomic study of SUMO-2 target proteins. J Biol Chem (2004) 1.92
p53- and Mdm2-independent repression of NF-kappa B transactivation by the ARF tumor suppressor. Mol Cell (2003) 1.92
SUMO-targeted ubiquitin E3 ligase RNF4 is required for the response of human cells to DNA damage. Genes Dev (2012) 1.90
Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection. Nat Struct Mol Biol (2004) 1.90
SUMO protease SENP1 induces isomerization of the scissile peptide bond. Nat Struct Mol Biol (2006) 1.89
Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH). Proc Natl Acad Sci U S A (2006) 1.87
Ribosomal proteins are targets for the NEDD8 pathway. EMBO Rep (2008) 1.84
SUMO and transcriptional regulation. Semin Cell Dev Biol (2004) 1.82
p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1. Mol Cell Biol (2003) 1.75
SNIP1 is a candidate modifier of the transcriptional activity of c-Myc on E box-dependent target genes. Mol Cell (2006) 1.73
Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit. EMBO J (2006) 1.73
Purification and identification of endogenous polySUMO conjugates. EMBO Rep (2011) 1.72
Transcriptional profiling of the LPS induced NF-kappaB response in macrophages. BMC Immunol (2007) 1.71
Identification of a substrate recognition site on Ubc9. J Biol Chem (2002) 1.71
Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation. Biochemistry (2003) 1.70
betaTrCP-mediated proteolysis of NF-kappaB1 p105 requires phosphorylation of p105 serines 927 and 932. Mol Cell Biol (2003) 1.69
Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor. EMBO J (2005) 1.69
Detection of protein SUMOylation in vivo. Nat Protoc (2009) 1.66
NEDP1, a highly conserved cysteine protease that deNEDDylates Cullins. J Biol Chem (2003) 1.64
Mechanism of ubiquitylation by dimeric RING ligase RNF4. Nat Struct Mol Biol (2011) 1.59
DNA-dependent acetylation of p53 by the transcription coactivator p300. J Biol Chem (2002) 1.59
Retracted A cell cycle regulatory network controlling NF-kappaB subunit activity and function. EMBO J (2007) 1.58
Comparative proteomic analysis identifies a role for SUMO in protein quality control. Sci Signal (2011) 1.54
Characterization of SENP7, a SUMO-2/3-specific isopeptidase. Biochem J (2009) 1.51
The structure of SENP1-SUMO-2 complex suggests a structural basis for discrimination between SUMO paralogues during processing. Biochem J (2006) 1.49
Structural basis of NEDD8 ubiquitin discrimination by the deNEDDylating enzyme NEDP1. EMBO J (2005) 1.48
Retracted The Skp2 promoter integrates signaling through the NF-kappaB, p53, and Akt/GSK3beta pathways to regulate autophagy and apoptosis. Mol Cell (2010) 1.34
Regulation of cyclin D1 RNA stability by SNIP1. Cancer Res (2008) 1.33
Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanism. J Biol Chem (2005) 1.33
The p68 and p72 DEAD box RNA helicases interact with HDAC1 and repress transcription in a promoter-specific manner. BMC Mol Biol (2004) 1.31
p53 and NF-kappaB crosstalk: IKKalpha tips the balance. Mol Cell (2007) 1.30
Stable-isotope labeling with amino acids in nematodes. Nat Methods (2011) 1.28
Differential regulation of c-Jun-dependent transcription by SUMO-specific proteases. J Biol Chem (2005) 1.28
Post-translational modification by SUMO. Toxicology (2010) 1.26
Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts. Proc Natl Acad Sci U S A (2007) 1.22
Regulation of cyclin D1 gene expression. Biochem Soc Trans (2010) 1.20
Regulation of NF-kappaB function. Biochem Soc Symp (2006) 1.18
Functional interactions between ubiquitin E2 enzymes and TRIM proteins. Biochem J (2011) 1.16
Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-kappaB transactivation. Cancer Res (2006) 1.15
The ETS domain transcription factor Elk-1 contains a novel class of repression domain. Mol Cell Biol (2002) 1.12
The protein stability and transcriptional activity of p63alpha are regulated by SUMO-1 conjugation. Cell Cycle (2005) 1.12
Highly efficient deletion of FUT8 in CHO cell lines using zinc-finger nucleases yields cells that produce completely nonfucosylated antibodies. Biotechnol Bioeng (2010) 1.12
Detection of modification by ubiquitin-like proteins. Methods (2006) 1.10
P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2. FEBS Lett (2002) 1.10
A fluorescence-resonance-energy-transfer-based protease activity assay and its use to monitor paralog-specific small ubiquitin-like modifier processing. Anal Biochem (2007) 1.10
Not just a CDK inhibitor: regulation of transcription by p21(WAF1/CIP1/SDI1). Cell Cycle (2002) 1.10
Nuclear factor-κB, p53, and mitochondria: regulation of cellular metabolism and the Warburg effect. Trends Biochem Sci (2012) 1.09
Ube2W conjugates ubiquitin to α-amino groups of protein N-termini. Biochem J (2013) 1.07
Arsenic-induced SUMO-dependent recruitment of RNF4 into PML nuclear bodies. Mol Biol Cell (2010) 1.07
IEX-1 directly interferes with RelA/p65 dependent transactivation and regulation of apoptosis. Biochim Biophys Acta (2007) 1.03
Inhibition of nuclear factor-kappaB activation un-masks the ability of TNF-alpha to induce human eosinophil apoptosis. Eur J Immunol (2002) 1.02
The role of RelA (p65) threonine 505 phosphorylation in the regulation of cell growth, survival, and migration. Mol Biol Cell (2011) 1.02
Regulation of the RelA (p65) transactivation domain. Biochem Soc Trans (2008) 1.02
A238L inhibits NF-ATc2, NF-kappa B, and c-Jun activation through a novel mechanism involving protein kinase C-theta-mediated up-regulation of the amino-terminal transactivation domain of p300. J Immunol (2008) 1.02
Regulation of RelA (p65) function by the large subunit of replication factor C. Mol Cell Biol (2003) 1.02
SUMOylation of HNF4α regulates protein stability and hepatocyte function. J Cell Sci (2012) 1.01
Differential regulation of NF-kappaB activation and function by topoisomerase II inhibitors. BMC Cancer (2006) 1.01
Quantitative analysis of multi-protein interactions using FRET: application to the SUMO pathway. Protein Sci (2008) 1.00
FRET-based in vitro assays for the analysis of SUMO protease activities. Methods Mol Biol (2009) 0.99
Conjugation of human topoisomerase 2 alpha with small ubiquitin-like modifiers 2/3 in response to topoisomerase inhibitors: cell cycle stage and chromosome domain specificity. Cancer Res (2008) 0.99
Identification of sites of ubiquitination in proteins: a fourier transform ion cyclotron resonance mass spectrometry approach. Anal Chem (2004) 0.99
The FHA domain protein SNIP1 is a regulator of the cell cycle and cyclin D1 expression. Oncogene (2004) 0.98
Identification and functional characterization of FMN2, a regulator of the cyclin-dependent kinase inhibitor p21. Mol Cell (2013) 0.97
Role of two residues proximal to the active site of Ubc9 in substrate recognition by the Ubc9.SUMO-1 thiolester complex. Biochemistry (2003) 0.96
Thr435 phosphorylation regulates RelA (p65) NF-kappaB subunit transactivation. Biochem J (2010) 0.96
Medea SUMOylation restricts the signaling range of the Dpp morphogen in the Drosophila embryo. Genes Dev (2008) 0.96
p53-dependent regulation of mitochondrial energy production by the RelA subunit of NF-κB. Cancer Res (2011) 0.95
Three-component synthesis and anticancer evaluation of polycyclic indenopyridines lead to the discovery of a novel indenoheterocycle with potent apoptosis inducing properties. Org Biomol Chem (2007) 0.95
Regulation of homeodomain-interacting protein kinase 2 (HIPK2) effector function through dynamic small ubiquitin-related modifier-1 (SUMO-1) modification. J Biol Chem (2005) 0.93
Retracted Regulation of activity and function of the p52 NF-κB subunit following DNA damage. Cell Cycle (2010) 0.92
NF-kappaB is a critical regulator of the survival of rodent and human hepatic myofibroblasts. J Hepatol (2008) 0.92
Absolute SILAC-compatible expression strain allows Sumo-2 copy number determination in clinical samples. J Proteome Res (2011) 0.92
The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability. Biochem J (2013) 0.91
The SUMO protease SENP6 is a direct regulator of PML nuclear bodies. Mol Biol Cell (2010) 0.91
Modulation of Abeta generation by small ubiquitin-like modifiers does not require conjugation to target proteins. Biochem J (2007) 0.90
Phenotypic screening with oleaginous microalgae reveals modulators of lipid productivity. ACS Chem Biol (2013) 0.89
NF-κB is a critical mediator of BRCA1-induced chemoresistance. Oncogene (2013) 0.88
Activation of NF-kappaB nuclear transcription factor by flow in human endothelial cells. Biochim Biophys Acta (2003) 0.87
A role for paralog-specific sumoylation in histone deacetylase 1 stability. J Mol Cell Biol (2013) 0.87
The p53-inhibitor pifithrin-alpha inhibits firefly luciferase activity in vivo and in vitro. BMC Mol Biol (2003) 0.87
Inhibition of RelA-Ser536 phosphorylation by a competing peptide reduces mouse liver fibrosis without blocking the innate immune response. Hepatology (2013) 0.86
BC-box protein domain-related mechanism for VHL protein degradation. Proc Natl Acad Sci U S A (2013) 0.86